PHILADELPHIA (September 8, 2025) — Fox Chase Cancer Center is pleased to announce the hiring of Conor Vickers, MD, as an Assistant Professor in the Section of Dermatology in the Department of Medicine. In addition to seeing patients at the main campus, Vickers will also see patients at Fox Chase – Huntingdon Pike and Fox Chase – Doylestown.
Vickers recently completed a fellowship in micrographic surgery and dermatologic oncology at Penn State College of Medicine. He brings to Fox Chase a strong background in clinical dermatology, dermatopathology, and surgical innovation, as well as a commitment to advancing dermatologic education and patient care through the development of cutting-edge medical technologies.
Vickers earned his medical degree from the Lewis Katz School of Medicine at Temple University, where he was inducted into the Alpha Omega Alpha Honor Medical Society and received the Excellence in Dermatology Award. He completed his residency in dermatology at Temple University Hospital, serving as Chief Resident, followed by a dermatopathology fellowship at Thomas Jefferson University’s Sidney Kimmel Medical College.
In addition to his clinical work, Vickers has distinguished himself as an innovative software developer, creating multiple educational and diagnostic tools used by clinicians and trainees. His projects include web and mobile platforms for dermatologic surgery education, digital pathology, secure image sharing, and clinical documentation. Notably, he co-developed the Mohs 3D Education Tool in collaboration with faculty at Fox Chase and created Derm Drive, a cloud-based electronic medical record system designed to reduce errors in dermatopathology and Mohs surgery.
Vickers has authored multiple peer-reviewed publications in leading dermatology journals and has presented his work on dermatologic measurement and surgical safety at national meetings. His unique combination of clinical expertise and technological acumen supports Fox Chase’s mission to provide world-class care and lead innovation in cancer treatment.